share_log

B of A Securities Maintains Buy on Kura Oncology, Lowers Price Target to $29

Benzinga ·  Nov 22 20:51  · Ratings

B of A Securities analyst Jason Zemansky maintains Kura Oncology (NASDAQ:KURA) with a Buy and lowers the price target from $36 to $29.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment